top of page

New England Consortium Node

PUBLICATIONS

Publications

New Publications

*Analysis of Health Trajectories Leading to Adverse Opioid-Related Events CTN-0099

*Prior NIDA CTN opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration, and discontinuation strategies for OUD pharmacotherapy (RDD) CTN-0100

*Models for Implementing ED-Initiated Buprenorphine With Referral for Ongoing Medication Treatment at ED Discharge in Diverse Academic Centers CTN-0099

*Development and testing of data infrastructure in the American College of Emergency Physicians' Clinical Emergency Data Registry for opioid-related research CTN-0081

*Missed Opportunities for HIV and Hepatitis C Screening Among ED Patients with Untreated OUD CTN-0099

*Identifying opioid-related electronic health record phenotypes for emergency care research and surveillance: An expert consensus driven concept mapping process CTN-0099

*The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study CTN OUD Core Outcome Standard Workgroup

Full list of protocol publications (select each protocol)

CTN-0030: Prescription Opioid Addiction Treatment Study (POATS)

Lead Investigator: Roger Weiss, MD
(Co-L with Pacific Region)

CTN-0081: Emergency Medicine Opioid Data Infrastructure: Key Venue to Address Opioid Morbidity and Mortality (Project CODE PRO--Capturing Opioid Use Disorder Electronically and Patient Reported Outcomes)

Lead Investigator: Arjun Venkatesh, MD, MBA, MHS

CTN-0069-A-2: The Impact of COVID-19 on Individuals with Opioid Use Disorder Who Received Emergency Department Care: A Survey Study of Project ED Health Participants and Medical Leadership at Four EDs

Lead Investigator: Jennifer Edelman, MD, MHS

CTN-0100: Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (NIH HEAL Initiative)

Lead Investigator: Roger Weiss, MD
(Co-L with New York Node)

CTN-0021: Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse

Lead Investigator: Kathleen Carroll, PhD
(Co-L with Florida Alliance)

CTN-0004: MET (Motivational Enhancement Treatment) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

Lead Investigator: Kathleen Carroll, PhD

CTN-0074: Prescription Opioid Addiction Treatment Study (POATS)

NECN Study Team Co-Is

Lead Investigator: Katharine Bradley, MD, MPH
(Health Systems Node)

CTN-0069: Opioid Use Disorder in the Emergency Department (Project ED Health)

Lead Investigators: Gail D'Onofrio, MD, MS & David Fiellin, MD

CTN-0069-A1:
Retrospective Evaluation of High Dose Buprenorphine Induction in the Emergency Department for Opioid Use Disorder

NECN Study Team Co-Is

Lead Investigator: Andrew Herring, MD
(Pacific Northwest Node)

bottom of page